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ABSTRACT 
The present study was conducted to determine the antinociceptive potential of methanol 
extract of Muntingia calabura L. (MEMC) and to isolate and identify the bioactive 
compound(s) responsible for the observed antinociceptive activity. The MEMC and its 
partitions (petroleum ether (PEP), ethyl acetate (EAP), and aqueous (AQP) partitions), in the 
dose range of 100, 500, and 1000 mg/kg, were tested using the formalin-induced nociceptive 
test. The PEP, which exerted the most effective activity in the respective early and late phase, 
was further subjected to the fractionation procedures and yielded seven fractions (labelled A 
to G). These fractions were tested, at the dose of 300 mg/kg, together with distilled water or 
10% DMSO (negative controls); morphine and aspirin (positive controls) for potential 
antinociceptive activity. Of all fractions, Fraction D showed the most significant 
antinociceptive activity, which is considered as equieffective to morphine or aspirin in the 
early or late phase, respectively. Further isolation and identification processes on fraction D 
led to the identification of three known and one new compounds, namely, 5-hydroxy-3,7,8-
trimethoxyflavone (1), 3,7-dimethoxy-5-hydroyflavone (2), 2′,4′-dihydroxy-3′-
methoxychalcone (3), and calaburone (4). At the dose of 50 mg/kg, compound 3 exhibited the 
highest percentage of antinociceptive activity in both phases of the formalin test. In 
conclusion, the antinociceptive activity of MEMC involved, partly, the synergistic activation 
of the flavonoid types of compounds. 
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